Annissa Rosser
Psychiatric/Mental Health · Warren, MINPI 1285290536
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 424 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,805, more than ten times the $238 reported in 2022. Among psychiatric/mental health clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 424 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$919
- Alkermes, Inc.$759
- plus $4K from 19 others
What the payments were for
- Food & beverage$9,95299%
- Education$1451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 62 | $1,442 |
| Johnson & Johnson | 53 | $1,312 |
| Teva Pharmaceuticals USA, Inc. | 54 | $1,122 |
| Neurocrine Biosciences, Inc. | 33 | $1,018 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 40 | $919 |
| Alkermes, Inc. | 27 | $759 |
| Otsuka America Pharmaceutical, Inc. | 30 | $611 |
| Corium, LLC | 32 | $564 |
| E.r. Squibb & Sons, L.L.C. | 18 | $458 |
| Indivior Inc. | 17 | $345 |
| Supernus Pharmaceuticals, Inc. | 18 | $319 |
| Axsome Therapeutics, Inc. | 5 | $293 |
| Lundbeck LLC | 11 | $188 |
| Vanda Pharmaceuticals Inc. | 7 | $141 |
| Noven Pharmaceuticals, Inc. | 1 | $125 |
| Idorsia Pharmaceuticals US Inc | 1 | $121 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Ironshore Pharmaceuticals Inc. | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Tempus AI, Inc | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $17 |
| Scpharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$610
- INGREZZA$508
- LYBALVI$479
- Austedo XR$362
- INVEGA SUSTENNA$335
- Auvelity$241
- CAPLYTA$229
- COBENFY$127
- ABILIFY MAINTENA$125
- ABILIFY ASIMTUFII$125
- Xelstrym$125
- QUVIVIQ$121
- UZEDY$119
- Azstarys$107
How this compares
$10,097 in reported general payments places this provider in the 95th percentile of 638 psychiatric/mental health providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 11 | $13,217 |
| Bupropion XlBupropion Hcl | 32 | $1,592 |
| Hydroxyzine Hcl | 25 | $679 |
| Glycopyrrolate | 11 | $394 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 37 | $372 |
| Quetiapine Fumarate | 45 | $354 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $333 |
| Buspirone Hcl | 15 | $316 |
| Duloxetine Hcl | 19 | $298 |
| Propranolol Hcl | 18 | $295 |
| Lorazepam | 24 | $173 |
| Mirtazapine | 13 | $173 |
| Divalproex Sodium | 12 | $172 |
| Lithium Carbonate ErLithium Carbonate | 11 | $159 |
| Alprazolam | 34 | $155 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Warren
- Jessica ShantzWarren$21K
- Howard ChangWarren$5K
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Gladys KimeliSaginaw$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.